CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Conjunctivitis - allergic - Management
Quick answers
- Scenario: Seasonal or perennial allergic conjunctivitis: covers the management of seasonal conjunctivitis that is characterized by recurrent conjunctivitis often at the same time each year, and the management of perennial conjunctivitis that is characterized by daily symptoms of conjunctivitis throughout the year, often on waking each morning.
- Scenario: Giant papillary conjunctivitis: covers the management of where macropapillae (0.3–1 mm) and giant papillae (1–2 mm) present on the inside of the upper lid. It occurs predominantly in people using contact lenses, although it may occur in people following eye surgery. Symptoms generally progress slowly. When caused by contact lenses, the person experiences increased awareness when wearing the lenses.
- Scenario: Contact dermatoconjunctivitis: covers the management of people with allergic dermatitis of the eyelids. It occurs most commonly in a person using eye drops and does not occur more frequently in people with atopy and does not respond to use of antihistamines and mast cell stabilizers.
© NHS Institute for Innovation and Improvement